Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives

News

 17th June 2011 Thermo Fisher Scientific

Thermo Fisher Scientific Introduces New Range of Solid Core HPLC Columns at HPLC 2011 Thermo Scientific Accucore HPLC Columns Offer Ultimate Core Performance to Maximize Investment

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the release of the Thermo Scientific Accucore HPLC column range. Founded on state-of-the-art Core Enhanced Technology and utilizing vast experience in phase bonding and packing, these columns provide a unique chromatography solution to enhance laboratory workflow and efficiency. Available in a wide range of stationary phase selectivities and compatible with almost any instrument, these columns give increased sensitivity and peak resolution, providing excellent return on investment. Thermo Fisher will showcase the Accucore™ HPLC column range at booth M11-12 during the 36th International Symposium on High-Performance Liquid Phase Separations and Related Techniques (HPLC 2011), June 19-23, Budapest, Hungary.

Containing solid core particles, which are engineered to a diameter of 2.6 µm and an average particle size distribution (D90/10) of 1.12, the Thermo Scientific Accucore HPLC column range allows high-speed, high-resolution separation, with backpressures significantly lower than those associated with UHPLC. The advanced bonding technology used in Accucore HPLC columns results in excellent peak shapes through high bonding coverage and minimized secondary interactions. The automated packing processes deployed in column manufacture produce uniform tightly packed columns, which are robust and reproducible.

For more information on Accucore HPLC columns please visit: www.thermoscientific.com/Accucore.

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.


 

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |